ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS)

CAPS Rating: 3 out of 5

The Company is a biopharmaceutical company exploiting proprietary RNA-based drug discovery technologies to create a new class of drugs to treat important diseases.

Recs

0
Player Avatar RXDOC73 (99.13) Submitted: 11/22/2011 8:17:23 AM : Outperform Start Price: $6.59 ISIS Score: +37.92

Buyout Potential!

Featured Broker Partners


Advertisement